Opinion on Pharmaceuticals and Healthcare in Europe

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Multiple sclerosis: NICE to reconsider decision

Published By Datamonitor
09 Nov 2000
CommentWire
CommentWire

Raisio: Benecol isn't beneficial to the bottom line

Published By Datamonitor
09 Nov 2000
CommentWire
CommentWire

BASF: farewell to pharma

Published By Datamonitor
16 Nov 2000
Expert View
Expert View

Opening the door to Japanese markets

Published By Datamonitor
08 Dec 2000
CommentWire
CommentWire

Glaxo Wellcome: biomarkers make their mark

Published By Datamonitor
08 Dec 2000
CommentWire
CommentWire

Shire Pharmaceuticals: transatlantic growth spurt

Published By Datamonitor
11 Dec 2000
CommentWire
CommentWire

Vernalis: benefiting from SB's regulatory headaches

Published By Datamonitor
14 Dec 2000
Expert View
Expert View

Piggy backing on organ transplants

Published By Datamonitor
22 Dec 2000
CommentWire
CommentWire

Aventis: non-core no more

Published By Datamonitor
05 Jan 2001
CommentWire
CommentWire

Stryker/Curis: bone regeneration protein should see strong growth

Published By Datamonitor
08 Jan 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.